{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:12Z","timestamp":1787995032058,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The science and technology program of yantai city","award":["2020YD024"],"award-info":[{"award-number":["2020YD024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10067-026-08265-x","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:17:27Z","timestamp":1783322247000},"page":"5307-5319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human epididymis protein 4: a potential prognostic biomarker for rheumatoid arthritis-associated interstitial lung disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Meihua","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenchun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-7234","authenticated-orcid":false,"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"23","key":"8265_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205\u20132219","journal-title":"N Engl J Med"},{"issue":"23","key":"8265_CR2","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S et al (2018) MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease. N Engl J Med 379(23):2209\u20132219","journal-title":"N Engl J Med"},{"issue":"6","key":"8265_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"8265_CR4","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ et al (2018) Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 198(5):e44\u2013e68","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"8265_CR5","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205(9):e18\u2013e47","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"8265_CR6","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62(6):1583\u20131591","journal-title":"Arthritis Rheum"},{"issue":"5","key":"8265_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.55563\/clinexprheumatol\/h9tc57","volume":"39","author":"MS Fazeli","year":"2021","unstructured":"Fazeli MS, Khaychuk V, Wittstock K, Han X, Crocket G, Lin M et al (2021) Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk\/prognostic factors, and treatment landscape. Clin Exp Rheumatol 39(5):1108\u20131118","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"8265_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","volume":"46","author":"K Raimundo","year":"2019","unstructured":"Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A et al (2019) Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol 46(4):360\u2013369","journal-title":"J Rheumatol"},{"issue":"2","key":"8265_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","volume":"45","author":"C Kirchhoff","year":"1991","unstructured":"Kirchhoff C, Habben I, Ivell R, Krull N (1991) A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors. Biol Reprod 45(2):350\u2013357","journal-title":"Biol Reprod"},{"issue":"5","key":"8265_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41416-023-02560-z","volume":"130","author":"C Young Han","year":"2024","unstructured":"Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M et al (2024) Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer. Br J Cancer 130(5):861\u2013868","journal-title":"Br J Cancer"},{"key":"8265_CR11","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16424","volume":"11","author":"W Zhong","year":"2023","unstructured":"Zhong W, Liu Y, Zhang L, Zhuang W, Chen J, Huang Z et al (2023) Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer. PeerJ 11:e16424","journal-title":"PeerJ"},{"key":"8265_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cca.2016.02.002","volume":"455","author":"Q Zeng","year":"2016","unstructured":"Zeng Q, Liu M, Zhou N, Liu L, Song X (2016) Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer. Clin Chim Acta 455:102\u2013106","journal-title":"Clin Chim Acta"},{"issue":"7","key":"8265_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/10408363.2025.2512467","volume":"62","author":"M Qiu","year":"2025","unstructured":"Qiu M, Zou S, Yu Z, Nian X (2025) Clinical utility of human epididymis protein 4. Crit Rev Clin Lab Sci 62(7):510\u2013534","journal-title":"Crit Rev Clin Lab Sci"},{"key":"8265_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119682","volume":"559","author":"Z Yu","year":"2024","unstructured":"Yu Z, Nian C, Sun W, Liu X, Nian X (2024) Elevated serum HE4 levels as a novel biomarker of disease severity and hepatic fibrosis in autoimmune hepatitis. Clin Chim Acta 559:119682","journal-title":"Clin Chim Acta"},{"issue":"2","key":"8265_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nm.2989","volume":"19","author":"VS LeBleu","year":"2013","unstructured":"LeBleu VS, Teng Y, O\u2019Connell JT, Charytan D, M\u00fcller GA, M\u00fcller CA et al (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19(2):227\u2013231","journal-title":"Nat Med"},{"issue":"1","key":"8265_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cardfail.2016.05.002","volume":"23","author":"A Piek","year":"2017","unstructured":"Piek A, Meijers WC, Schroten NF, Gansevoort RT, de Boer RA, Sillj\u00e9 HH (2017) HE4 serum levels are associated with heart failure severity in patients with chronic heart failure. J Card Fail 23(1):12\u201319","journal-title":"J Card Fail"},{"issue":"11","key":"8265_CR17","first-page":"2167","volume":"40","author":"T Lin","year":"2022","unstructured":"Lin T, Xu S, Wang Y, Nian X, Shan X, Jiang T et al (2022) Human epididymis protein 4 as a new diagnostic biomarker for rheumatoid arthritis-associated interstitial lung disease. Clin Exp Rheumatol 40(11):2167\u20132174","journal-title":"Clin Exp Rheumatol"},{"key":"8265_CR18","doi-asserted-by":"publisher","first-page":"755268","DOI":"10.3389\/fmed.2021.755268","volume":"8","author":"L Liang","year":"2021","unstructured":"Liang L, Chen J, Di C, Zhan M, Bao H, Xia C et al (2021) Serum human epididymis protein 4 as a novel biomarker in identifying patients with interstitial lung disease in rheumatoid arthritis. Front Med (Lausanne) 8:755268","journal-title":"Front Med (Lausanne)"},{"key":"8265_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108704","volume":"108","author":"K Meng","year":"2022","unstructured":"Meng K, Tian M, Gui X, Xie M, Gao Y, Shi S et al (2022) Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern. Int Immunopharmacol 108:108704","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"8265_CR20","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69(9):1580\u20131588","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"8265_CR21","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL et al (2019) Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 200(8):e70\u2013e88","journal-title":"Am J Respir Crit Care Med"},{"key":"8265_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109609","volume":"115","author":"F Sun","year":"2023","unstructured":"Sun F, Zhao J, Li Y, Wang H, Cao X, Cheng W et al (2023) Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies. Int Immunopharmacol 115:109609","journal-title":"Int Immunopharmacol"},{"key":"8265_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320956420","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang M, Zhang L, E L, Xu K, Wang XF, Zhang B et al (2020) Increased levels of HE4 (WFDC2) in systemic sclerosis: a novel biomarker reflecting interstitial lung disease severity? Ther Adv Chronic Dis 11:2040622320956420","journal-title":"Ther Adv Chronic Dis"},{"issue":"9","key":"8265_CR24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s13258-019-00836-4","volume":"41","author":"J Wang","year":"2019","unstructured":"Wang J, Zhao H, Xu F, Zhang P, Zheng Y, Jia N (2019) Human epididymis protein 4 (HE4) protects against cystic pulmonary fibrosis associated-inflammation through inhibition of NF-\u03baB and MAPK signaling. Genes Genomics 41(9):1045\u20131053","journal-title":"Genes Genomics"},{"key":"8265_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.670642","volume":"12","author":"J Chen","year":"2021","unstructured":"Chen J, Sun F, Bao H, Liang L, Zhan M, Yao H et al (2021) Elevated serum human epididymis protein 4 is associated with disease activity and systemic involvements in primary Sj\u00f6gren\u2019s syndrome. Front Immunol 12:670642","journal-title":"Front Immunol"},{"issue":"1","key":"8265_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1465-9921-7-61","volume":"7","author":"L Bingle","year":"2006","unstructured":"Bingle L, Cross SS, High AS, Wallace WA, Rassl D, Yuan G et al (2006) WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res 7(1):61","journal-title":"Respir Res"},{"issue":"5","key":"8265_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13774","volume":"18","author":"T Zhang","year":"2024","unstructured":"Zhang T, Chu L, Tan W, Ye C, Dong H (2024) Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer. Clin Respir J 18(5):e13774","journal-title":"Clin Respir J"},{"issue":"6","key":"8265_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41416-019-0718-9","volume":"122","author":"HJ Whitwell","year":"2020","unstructured":"Whitwell HJ, Worthington J, Blyuss O, Gentry-Maharaj A, Ryan A, Gunu R et al (2020) Improved early detection of ovarian cancer using longitudinal multimarker models. Br J Cancer 122(6):847\u2013856","journal-title":"Br J Cancer"},{"issue":"6","key":"8265_CR29","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1097\/IGC.0000000000000737","volume":"26","author":"AR Simmons","year":"2016","unstructured":"Simmons AR, Clarke CH, Badgwell DB, Lu Z, Sokoll LJ, Lu KH et al (2016) Validation of a biomarker panel and longitudinal biomarker performance for early detection of ovarian cancer. Int J Gynecol Cancer 26(6):1070\u20131077","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"8265_CR30","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1093\/rheumatology\/keaa836","volume":"60","author":"JA Sparks","year":"2021","unstructured":"Sparks JA, Jin Y, Cho SK, Vine S, Desai R, Doyle TJ et al (2021) Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford) 60(8):3689\u20133698","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"8265_CR31","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E et al (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76(10):1700\u20131706","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"8265_CR32","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/acr2.11736","volume":"6","author":"EL Matteson","year":"2024","unstructured":"Matteson EL, Bendstrup E, Strek ME, Dieud\u00e9 P (2024) Clinical course of interstitial lung disease in patients with rheumatoid arthritis. ACR Open Rheumatol 6(12):836\u2013845","journal-title":"ACR Open Rheumatol"},{"key":"8265_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0210-2022","author":"GM Joy","year":"2023","unstructured":"Joy GM, Arbiv OA, Wong CK, Lok SD, Adderley NA, Dobosz KM et al (2023) Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis. Eur Respir Rev. https:\/\/doi.org\/10.1183\/16000617.0210-2022","journal-title":"Eur Respir Rev"},{"issue":"1","key":"8265_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.resinv.2020.08.002","volume":"59","author":"N Nishiyama","year":"2021","unstructured":"Nishiyama N, Masuo M, Nukui Y, Tateishi T, Kishino M, Tateishi U et al (2021) Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease. Respir Investig 59(1):90\u201398","journal-title":"Respir Investig"},{"key":"8265_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01829-0","author":"M Tian","year":"2024","unstructured":"Tian M, Zhu X, Ren L, Zhou X, Gu L, Meng K et al (2024) HE4-based nomogram for predicting overall survival in patients with idiopathic pulmonary fibrosis: construction and validation. Eur J Med Res. https:\/\/doi.org\/10.1186\/s40001-024-01829-0","journal-title":"Eur J Med Res"},{"issue":"18","key":"8265_CR36","doi-asserted-by":"publisher","first-page":"992","DOI":"10.21037\/atm-22-4042","volume":"10","author":"M Tian","year":"2022","unstructured":"Tian M, Meng K, Gao Y, Zhang J, Xie M, Tian Y et al (2022) Elevated serum human epididymis protein 4 is associated with disease severity and worse survival in idiopathic pulmonary fibrosis: a cohort study. Ann Transl Med 10(18):992","journal-title":"Ann Transl Med"},{"issue":"3","key":"8265_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2021.105133","volume":"88","author":"M Ekici","year":"2021","unstructured":"Ekici M, Baytar Y, Kardas RC, Sari A, Akdogan A, Durhan G et al (2021) Predictors of mortality in rheumatoid arthritis-associated lung disease: a retrospective study on ten years. Jt Bone Spine 88(3):105133","journal-title":"Jt Bone Spine"},{"issue":"6","key":"8265_CR38","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH et al (2010) Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35(6):1322\u20131328","journal-title":"Eur Respir J"},{"key":"8265_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.rmed.2017.03.027","volume":"126","author":"ZX Yunt","year":"2017","unstructured":"Yunt ZX, Chung JH, Hobbs S, Fernandez-Perez ER, Olson AL, Huie TJ et al (2017) High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival. Respir Med 126:100\u2013104","journal-title":"Respir Med"},{"issue":"4","key":"8265_CR40","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","volume":"38","author":"Q Fu","year":"2019","unstructured":"Fu Q, Wang L, Li L, Li Y, Liu R, Zheng Y (2019) Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population. Clin Rheumatol 38(4):1109\u20131116","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8265_CR41","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A et al (2016) Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 47(2):588\u2013596","journal-title":"Eur Respir J"},{"issue":"3","key":"8265_CR42","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.chest.2016.04.006","volume":"150","author":"B Nagy Jr.","year":"2016","unstructured":"Nagy B Jr., Nagy B, Fila L, Clarke LA, G\u00f6nczy F, Bede O et al (2016) Human epididymis protein 4: a novel serum inflammatory biomarker in cystic fibrosis. Chest 150(3):661\u2013672","journal-title":"Chest"},{"issue":"11","key":"8265_CR43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/CM9.0000000000000785","volume":"133","author":"HY Cheng","year":"2020","unstructured":"Cheng HY, Zeng L, Ye X, Ma RQ, Tang ZJ, Chu HL et al (2020) Age and menopausal status are important factors influencing the serum human epididymis secretory protein 4 level: a prospective cross-sectional study in healthy Chinese people. Chin Med J (Engl) 133(11):1285\u20131291","journal-title":"Chin Med J (Engl)"},{"key":"8265_CR44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cca.2014.07.040","volume":"438","author":"J Kappelmayer","year":"2015","unstructured":"Kappelmayer J, Antal-Szalm\u00e1s P, Nagy B Jr (2015) Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders. Clin Chim Acta 438:35\u201342","journal-title":"Clin Chim Acta"},{"key":"8265_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1072531","volume":"12","author":"Q Miao","year":"2022","unstructured":"Miao Q, Cai B, Niu Q, Zhang J (2022) Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit. Front Oncol 12:1072531","journal-title":"Front Oncol"},{"issue":"1","key":"8265_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ygyno.2016.07.100","volume":"143","author":"S Yu","year":"2016","unstructured":"Yu S, Lee JK, Kim JH, Park H, Lee MY, Ryu S et al (2016) Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women. Gynecol Oncol 143(1):128\u2013134","journal-title":"Gynecol Oncol"},{"issue":"1","key":"8265_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s42003-025-07529-7","volume":"8","author":"W Zheng","year":"2025","unstructured":"Zheng W, Zou M, Hu X, Gao H, Song W, Hou Q et al (2025) Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosis. Commun Biol 8(1):93","journal-title":"Commun Biol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08265-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08265-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08265-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:35:40Z","timestamp":1787992540000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-08265-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["8265"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08265-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Yantai Yuhuangding Hospital (approval no. 2025\u2013112).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}